<ul>
<li>PW Medtech held its annual general meeting on June 26, 2026; shareholders adopted the audited 2025 financial statements and related reports.     *      A final dividend of HKD 0.02 per share for 2025 was declared; the resolution authorizes the payout but does not confirm payment.     *      Shareholders backed the continued appointment of BDO as auditor; the decision authorizes setting the audit fee.     *      Resolutions to retain Yue’e Zhang as executive director and Chen Geng as independent non-executive director were carried.     *      General mandates to repurchase shares, issue new shares, and extend the issuance mandate by shares repurchased were approved. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PW Medtech Group Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260626-12218028), on June 26, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)</li>
</ul>

01358

<p>PW Medtech held its annual general meeting on June 26, 2026, with all resolutions passed. Shareholders approved the 2025 financial statements, declared a final dividend of HKD 0.02 per share, and reappointed BDO as auditor. The company also retained directors Yue’e Zhang and Chen Geng, and approved general mandates for share repurchases and new issuances.</p>

PUBT

PW Medtech held annual shareholder meeting, poll results showed all resolutions passed